Skip to content

Measurement of Antioxidant Activity on Postoperative Inflammation in Patients Undergoing Ophthalmic Surgery

Effects of Laser Species and Ocular Antioxidant Activity on Postoperative Inflammation and Visual Prognosis in Patients Undergoing Ophthalmic Surgery - a Comparative Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05905237
Enrollment
132
Registered
2023-06-15
Start date
2022-07-12
Completion date
2023-07-28
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Myopia

Keywords

antioxidants

Brief summary

This trial hypothesized that novel laser refractive surgery techniques (PRK, LASIK, SMILE) or laser-assisted cataract surgery (FLACAS) could suppress postoperative inflammation and improve recovery in patients by reducing oxidative stress generated by the surgical procedure. It is also intended to verify whether the new laser technology is necessary for clinical use in groups with low antioxidant activity through the detection of antioxidant activity in the eyes of patients.

Interventions

PROCEDURECataract surgery, Femtosecond-LASIK, SMILE

Cataract surgery includes both conventional and femtosecond laser assisted. Femtosecond-LASIK and SMILE are options for patients to correct myopia.

Sponsors

Nobel Eye Institute
CollaboratorUNKNOWN
Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* over 20 years old (included) * corneal refractive surgery or cataract surgery patients

Exclusion criteria

* patients with eye infections * presence of severe retinal disease * presence of severe eye injury or severe ptosis

Design outcomes

Primary

MeasureTime frame
Change of Ascorbic Acid (AA) in aqueous humor from Baseline to one day after surgery.During the operation and one day after surgery.
Change of Total Antioxidant Capacity (TAC) in tears from Baseline to 1 month after surgery.Before the operation and 1 month after surgery.
Change of Total Antioxidant Capacity (TAC) in tears from Baseline to 1 week after surgery.Before the operation and 1 week after surgery.
Change of Total Antioxidant Capacity (TAC) in tears from Baseline to 3 months after surgery.Before the operation and 3 months after surgery.
Change of Total Antioxidant Capacity (TAC) in tears from Baseline to 6 months after surgery.Before the operation and 6 months after surgery.
Change of Ascorbic Acid (AA) in tears from Baseline to 1 week after surgery.Before the operation and 1 week after surgery.
Change of Ascorbic Acid (AA) in tears from Baseline to 1 month after surgery.Before the operation and 1 month after surgery.
Change of Ascorbic Acid (AA) in tears from Baseline to 3 months after surgery.Before the operation and 3 months after surgery.
Change of Ascorbic Acid (AA) in tears from Baseline to 6 months after surgery.Before the operation and 6 months after surgery.
Change of Total Antioxidant Capacity (TAC) in aqueous humor from Baseline to one day after surgery.During the operation and one day after surgery.

Secondary

MeasureTime frame
Examination of uncorrected visual acuity (UCVA).Before the operation.
Examination of intraocular pressure (IOP).Before the operation.
Examination of central corneal thickness (CCT).Before the operation.
Examination of axial length (AXL).Before the operation.
Examination of anterior chamber depth (ACD).Before the operation.
Examination of lens thickness (LT).Before the operation.
Examination of manifest refraction.Before the operation.
Examination of corneal curvature.Before the operation.
Examination of best corrected visual acuity (BCVA).Before the operation.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026